Ptc Therapeutics (PTCT) Receivables - Net (2013 - 2026)
Ptc Therapeutics (PTCT) reported Receivables - Net of $239.04 million for Q2 2026, up 21.9% from $196.13 million a year earlier and up 8.7% from the prior quarter.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Receivables - Net (2013 - 2026) Analysis & Trends
At the end of FY2025, Ptc Therapeutics posted Receivables - Net of $181.62 million, up 14.5% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
- By year, Receivables - Net came in at $158.55 million in FY2024 (-1.4%), $160.82 million in FY2023 (+3.3%), $155.61 million in FY2022 (+40.9%) and $110.46 million in FY2021 (+58.0%).
- The Q2 2026 figure ranks as the highest quarterly Receivables - Net in data going back to Q4 2013.
- Year over year, Receivables - Net has now increased in each of the last six quarters, with growth averaging 9.1% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q2 2022 (growth of 72.5%); the low point was Q1 2024 (a decline of 2.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $219.92 million (Q1 2026), $181.62 million (Q4 2025) and $203.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ptc Therapeutics | 5.50 Bn | -2.26 Bn | 340.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239.04 Mn |
| Mar 31, 2026 | 219.92 Mn |
| Dec 31, 2025 | 181.62 Mn |
| Sep 30, 2025 | 203.07 Mn |
| Jun 30, 2025 | 196.13 Mn |
| Mar 31, 2025 | 210.50 Mn |
| Dec 31, 2024 | 158.55 Mn |
| Sep 30, 2024 | 199.98 Mn |
| Jun 30, 2024 | 187.15 Mn |
| Mar 31, 2024 | 197.66 Mn |
| Dec 31, 2023 | 160.82 Mn |
| Sep 30, 2023 | 165.72 Mn |
| Jun 30, 2023 | 177.50 Mn |
| Mar 31, 2023 | 201.87 Mn |
| Dec 31, 2022 | 155.61 Mn |
| Sep 30, 2022 | 124.46 Mn |
| Jun 30, 2022 | 135.94 Mn |
| Mar 31, 2022 | 141.29 Mn |
| Dec 31, 2021 | 110.46 Mn |
| Sep 30, 2021 | 96.65 Mn |
API Access
Ptc Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PTCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();